ACTO

ACTO is a Canadian startup founded in 2014 with the slogan "Field Force Effectiveness in Biopharma." The company offers an AI-powered Intelligent Field Excellence platform tailored for the Life Sciences industry. This platform aims to enhance customer engagement and brand performance by empowering Sales, Marketing, and Medical teams. The platform's focus is on transforming field professionals into "Masters of the Message," ensuring that they engage with healthcare professionals and their support teams with authority and impact. The solution provided by ACTO equips biopharmaceutical companies to guarantee the competence, confidence, and credibility of their field professionals, enabling them to deliver the correct message to healthcare professionals during face-to-face interactions. Furthermore, ACTO provides senior leaders and frontline managers with valuable insights to drive continuous field force effectiveness. The startup operates in the Education, Health Care, and SaaS industries. Most recently, ACTO secured an $18.00M Series B investment on July 7, 2022, with funding from a consortium of investors including Panache Ventures, MaRS IAF, Salesforce Ventures, Questa Capital, and Resolve Growth Partners.